Transthyretin Amyloidosis (ATTR) Market Report

Global and China Transthyretin Amyloidosis (ATTR) Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 10, 2022
  • PAGES：165
  • REPORT CODE：GMM1453158
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Transthyretin Amyloidosis (ATTR) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Corino Therapeutics

    • Alnylam Pharmaceuticals

    • Ionis Pharmaceuticals

    • Proclara Bioscience

    • Arcturus Therapeutics

    • Pfizer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Hereditary ATTR (HATTR)

    • Wild-Type (WT) ATTR

    Application:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Transthyretin Amyloidosis (ATTR) Industry Overview

      • 1.1.1 Transthyretin Amyloidosis (ATTR) Market Scope and Market Segments

      • 1.1.2 Transthyretin Amyloidosis (ATTR) Industry Characteristics

      • 1.1.3 Global and China Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Transthyretin Amyloidosis (ATTR) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Hereditary ATTR (HATTR)

      • 1.2.2 Wild-Type (WT) ATTR

    • 1.3 Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Ambulatory Surgical Centers

      • 1.3.3 Diagnostic Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Transthyretin Amyloidosis (ATTR) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Transthyretin Amyloidosis (ATTR) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Transthyretin Amyloidosis (ATTR) Industry PEST Analysis

    • 2.3 Transthyretin Amyloidosis (ATTR) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Transthyretin Amyloidosis (ATTR) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Transthyretin Amyloidosis (ATTR) Industry

    Chapter 3 Global and China Transthyretin Amyloidosis (ATTR) Market, by Manufacturer

    • 3.1 Global and China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Transthyretin Amyloidosis (ATTR) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Transthyretin Amyloidosis (ATTR) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Transthyretin Amyloidosis (ATTR) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Transthyretin Amyloidosis (ATTR) Market Top 3 Players

    Chapter 4 Global and China Transthyretin Amyloidosis (ATTR) Market, by Type (2017-2028)

    • 4.1 Transthyretin Amyloidosis (ATTR) Market Trend, by Type

    • 4.2 Global Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Transthyretin Amyloidosis (ATTR) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Transthyretin Amyloidosis (ATTR) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Transthyretin Amyloidosis (ATTR) Price Trend, by Type (2017-2028)

    • 4.3 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Transthyretin Amyloidosis (ATTR) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Transthyretin Amyloidosis (ATTR) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Transthyretin Amyloidosis (ATTR) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Transthyretin Amyloidosis (ATTR) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Transthyretin Amyloidosis (ATTR) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Transthyretin Amyloidosis (ATTR) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Transthyretin Amyloidosis (ATTR) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Transthyretin Amyloidosis (ATTR) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Transthyretin Amyloidosis (ATTR) Market Analysis

    • 7.1 North America Transthyretin Amyloidosis (ATTR) Market, by Type

    • 7.2 North America Transthyretin Amyloidosis (ATTR) Market, by Application

    • 7.3 North America Transthyretin Amyloidosis (ATTR) Market Analysis and Forecast, by Country

      • 7.3.1 United States Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Transthyretin Amyloidosis (ATTR) Market Analysis

    • 8.1 Europe Transthyretin Amyloidosis (ATTR) Market, by Type

    • 8.2 Europe Transthyretin Amyloidosis (ATTR) Market, by Application

    • 8.3 Europe Transthyretin Amyloidosis (ATTR) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Transthyretin Amyloidosis (ATTR) Market Analysis

    • 9.1 APAC Transthyretin Amyloidosis (ATTR) Market, by Type

    • 9.2 APAC Transthyretin Amyloidosis (ATTR) Market, by Application

    • 9.3 APAC Transthyretin Amyloidosis (ATTR) Market Analysis and Forecast, by Country

      • 9.3.1 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Market Analysis

    • 10.1 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Market, by Type

    • 10.2 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Market, by Application

    • 10.3 Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Transthyretin Amyloidosis (ATTR) Company Profiles

      • 11.1 Corino Therapeutics

        • 11.1.1 Corino Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.1.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Alnylam Pharmaceuticals

        • 11.2.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ionis Pharmaceuticals

        • 11.3.1 Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Proclara Bioscience

        • 11.4.1 Proclara Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.4.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Arcturus Therapeutics

        • 11.5.1 Arcturus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.5.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Transthyretin Amyloidosis (ATTR) Product Profiles, Application and Specification

        • 11.6.3 Pfizer Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Transthyretin Amyloidosis (ATTR) Industry Investment Prospect and Risk Assessment

    • 12.1 Transthyretin Amyloidosis (ATTR) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Transthyretin Amyloidosis (ATTR) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Production Value and Growth Rate (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Value and Growth Rate (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hereditary ATTR (HATTR) (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Wild-Type (WT) ATTR (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Diagnostic Centers (2017-2028)

    • Figure North America Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Transthyretin Amyloidosis (ATTR) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Transthyretin Amyloidosis (ATTR) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Transthyretin Amyloidosis (ATTR) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Transthyretin Amyloidosis (ATTR) Market Share, by Manufacturer in 2021

    • Figure Global and China Transthyretin Amyloidosis (ATTR) Market Share, by Manufacturer in 2022

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Value, by Type (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Value Share, by Type (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Price Trend, by Type (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value, by Type (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value Share, by Type (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Price Trend, by Type (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Value, by Application (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Sales Value Share, by Application (2017-2028)

    • Figure Global Transthyretin Amyloidosis (ATTR) Sales Value Share, by Application (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value, by Application (2017-2028)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value Share, by Application (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Value Share, by Application (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Production, Import, Consumption and Export (2017-2022)

    • Table North America Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table North America Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure North America Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table North America Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table North America Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure North America Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure United States Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Table Europe Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table Europe Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table Europe Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table Europe Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure UK Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure France Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure France Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Table APAC Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table APAC Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table APAC Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table APAC Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure India Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure India Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Transthyretin Amyloidosis (ATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Transthyretin Amyloidosis (ATTR) Sales Value and Growth Rate (2017-2028)

    • Table Corino Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Corino Therapeutics Product Profiles, Application and Specification

    • Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Proclara Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Proclara Bioscience Product Profiles, Application and Specification

    • Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arcturus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arcturus Therapeutics Product Profiles, Application and Specification

    • Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Transthyretin Amyloidosis (ATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US